Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Spirito

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|January 28, 2005
Glycogen storage diseases presenting as hypertrophic cardiomyopathyMichael Arad, Barry J Maron, Joshua M Gorham, et al.
JAMA|March 26, 2009
Clinical outcome and phenotypic expression in LAMP2 cardiomyopathyBarry J Maron, William C Roberts, Michael Arad, et al.
The American Journal of Cardiology|February 2, 2008
Heart transplantation in hypertrophic cardiomyopathyElena Biagini, Paolo Spirito, Ornella Leone, et al.
Journal of Cardiovascular Electrophysiology|March 9, 2007
Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathyYong-Mei Cha, Bernard J Gersh, Barry J Maron, et al.
International Journal of Molecular Medicine|September 8, 2016
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathyMassimiliano Cecconi, Maria I Parodi, Francesco Formisano, et al.
Circulation|March 25, 2009
Syncope and risk of sudden death in hypertrophic cardiomyopathyPaolo Spirito, Camillo Autore, Claudio Rapezzi, et al.
The American Journal of Cardiology|March 18, 2014
Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factorsPaolo Spirito, Camillo Autore, Francesco Formisano, et al.
Circulation. Arrhythmia and Electrophysiology|April 8, 2018
Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-DefibrillatorsBarry J Maron, Susan A Casey, Iacopo Olivotto, et al.
Circulation. Genomic and Precision Medicine|November 5, 2020
Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European RegistryDor Lotan, Joel Salazar-Mendiguchía, Jens Mogensen, et al.
The American Journal of Cardiology|July 20, 2014
Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathyElena Biagini, Iacopo Olivotto, Maria Iascone, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|January 28, 2005
Glycogen storage diseases presenting as hypertrophic cardiomyopathyMichael Arad, Barry J Maron, Joshua M Gorham, et al.
JAMA|March 26, 2009
Clinical outcome and phenotypic expression in LAMP2 cardiomyopathyBarry J Maron, William C Roberts, Michael Arad, et al.
The American Journal of Cardiology|February 2, 2008
Heart transplantation in hypertrophic cardiomyopathyElena Biagini, Paolo Spirito, Ornella Leone, et al.
Journal of Cardiovascular Electrophysiology|March 9, 2007
Electrophysiologic manifestations of ventricular tachyarrhythmias provoking appropriate defibrillator interventions in high-risk patients with hypertrophic cardiomyopathyYong-Mei Cha, Bernard J Gersh, Barry J Maron, et al.
International Journal of Molecular Medicine|September 8, 2016
Targeted next-generation sequencing helps to decipher the genetic and phenotypic heterogeneity of hypertrophic cardiomyopathyMassimiliano Cecconi, Maria I Parodi, Francesco Formisano, et al.
Circulation|March 25, 2009
Syncope and risk of sudden death in hypertrophic cardiomyopathyPaolo Spirito, Camillo Autore, Claudio Rapezzi, et al.
The American Journal of Cardiology|March 18, 2014
Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factorsPaolo Spirito, Camillo Autore, Francesco Formisano, et al.
Circulation. Arrhythmia and Electrophysiology|April 8, 2018
Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-DefibrillatorsBarry J Maron, Susan A Casey, Iacopo Olivotto, et al.
Circulation. Genomic and Precision Medicine|November 5, 2020
Clinical Profile of Cardiac Involvement in Danon Disease: A Multicenter European RegistryDor Lotan, Joel Salazar-Mendiguchía, Jens Mogensen, et al.
The American Journal of Cardiology|July 20, 2014
Significance of sarcomere gene mutations analysis in the end-stage phase of hypertrophic cardiomyopathyElena Biagini, Iacopo Olivotto, Maria Iascone, et al.
Pageof 5